Services

Intraoperative Radiotherapy (IORT)

Intraoperative Radiotherapy (IORT)

The Breast Unit at the Hospital of St John and St Elizabeth is the first private hospital in the UK to offer Intraoperative Radiotherapy (IORT).

This pioneering technique allows breast cancer sufferers to avoid up to 6 weeks of radiotherapy. Instead, IORT can be delivered in a single dose, directly to the breast during surgery.


Contact info

Self referral mammography is available for women over the age of 40 who have no obvious breast problems and have not had mammography within the past 12 months.

Women noticing a lump or any breast changes are advised to see their GP or contact The Breast Unit on: Tel – 020 7266 4272 or 020 7806 4000 ext. 4439; Fax–020 7806 4002 or email us at: imaging@hje.org.uk

Opening hours
Monday to Friday: 9.00am – 5.00pm

Find a Consultant

Make an Enquiry

Intraoperative Radiotherapy (IORT)

First in the UK

The Breast Unit at the Hospital of St John and St Elizabeth is the first private hospital in the UK to offer Intraoperative Radiotherapy (IORT).

This pioneering technique allows breast cancer sufferers to avoid up to 6 weeks of radiotherapy. Instead, IORT can be delivered in a single dose, directly to the breast during surgery.

An international clinical trial of IORT (known as TARGIT), published in the leading medical journal, the Lancet, found that IORT has a similar success rate to conventional radiotherapy with less side effects.

Who can have it?

An estimated 80% of all patients who undergo breast conserving surgery can be treated with this new method. Clinical studies show the recurrence rate is very low after a boost of IORT and subsequent shorter external beam radiotherapy.

A patient must be a suitable candidate in order to be eligible for breast cancer IORT. This treatment is generally reserved for individuals with early stage disease.

Two ways of delivering IORT

1.  Single dose
Single dose radiotherapy takes only 30 minutes and may be an option for patients with early-stage breast cancer often discovered in mammography screening. Targeted radiation is delivered with high precision after the tumour has been removed to preserve surrounding tissue and organs. With traditional radiotherapy the entire breast receives radiation, which exposes all the breast and surrounding tissue to a high dose of radiation for 6 weeks, 5 days a week. Considerable time and cost is saved by IORT.

2.  Boost therapy
Boost IORT is recommended to higher risk patients. It is applied in an identical manner to the single dose. However, these Boost IORT patients then have traditional radiotherapy, but save up to 10 days of external beam radiation. The pilot trial has reported one of the lowest recurrence rates after 5 years.

Funding

Most major insurance companies will cover the cost of IORT, subject to clinical criteria.